FDAFDA · Food and drugs·Recall number D-0366-2024
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
Published March 13, 2024 · Recall initiated: February 20, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- METHYLPREDNISOLONE ACETATE
- Manufacturer
- Eugia US LLC
- Distributor
- OH, TN, LA, MS
- UPC
- 0355150313013
- Lot
- Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.